Dernières nouvelles pour Alzamend Neuro (NASDAQ:ALZN) Stock

ALZAMEND NEURO INC

Alzamend Neuro

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Alzamend Neuro Inc

Shashank Patel, Chief Financial Officer at Watts Water Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTS#NYSE">WTS</a>), disclosed an insider sell on May 13, according to a recent SEC filing.
What Happened: Patel's decision to sell 8,000 shares of Watts Water Technologies was revealed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000795403/000122520825005002//Archives/edgar/data/795403/000122520825005002/0001225208-25-005002-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday. The total value of the sale is $1,960,003.
As of Tuesday morning, Watts Water Technologies shares are up by 0.46%, currently priced at $247.0.
<h3>Discovering Watts Water Technologies: A Closer Look</h3>
Watts Water Technologies Inc is a U.S.-based company that provides safety, energy efficiency, and water conservation products. Its product portfolio includes residential and commercial flow control products, which are sold for plumbing and hot water applications; HVAC and gas products, including commercial boilers, water heaters, heating solutions, etc.; drainage and water reuse products, including drainage products and engineered rainwater-harvesting solutions; and water quality products, including point-of-use and point-of-entry water filtration, conditioning, and scale prevention systems. Its products are marketed through brands like Watts, Apex, Bradley, Nexa, and others. Geographically, the company derives its key revenue from the Americas, followed by Europe and the APMEA region.
<h3>Watts Water Technologies's Financial Performance</h3>
Revenue Growth: Watts Water Technologies's revenue growth over a period of 3 months has faced challenges. As of 31 March, 2025, the company experienced a revenue decline of approximately -2.26%. This indicates a decrease in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Profitability Metrics:
<ul>
<li>
Gross Margin: Achieving a high gross margin of 48.84%, the company performs well in terms of cost management and profitability within its sector.
</li>
<li>
Earnings per Share (EPS): Watts Water Technologies's EPS is notably higher than the industry average. The company achieved a positive bottom-line trend with a current EPS of 2.21.
</li>
</ul>
Debt Management: Watts Water Technologies's debt-to-equity ratio is below the industry average at 0.11, reflecting a lower dependency on debt financing and a more conservative financial approach.
Financial Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a higher-than-average P/E ratio of 28.16, Watts Water Technologies's stock is perceived as being overvalued in the market.
</li>
<li>
Price to Sales (P/S) Ratio: With a relatively high Price to Sales ratio of 3.68 as compared to the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio 18.1 is above the industry average, suggesting that the market values the company more highly for each unit of EBITDA. This could be attributed to factors such as strong growth prospects or superior operational efficiency.
</li>
</ul>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Navigating the Impact of Insider Transactions on Investments</h3>
While insider transactions provide valuable information, they should be part of a broader analysis in making investment decisions.
From a legal standpoint, the term "insider" pertains to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as outlined in Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and significant hedge funds. These insiders are mandated to inform the public of their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
A company insider's new purchase is a indicator of their positive anticipation for a rise in the stock.
While insider sells may not necessarily reflect a bearish view and can be motivated by various factors.
<h3>Transaction Codes Worth Your Attention</h3>
In the domain of transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their focus to those taking place in the open market, as meticulously outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000795403">Check Out The Full List Of Watts Water Technologies's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Insider Trades

Trading Ideas

Sell Alert: Shashank Patel Cashes Out $1.96M In Watts Water Technologies Stock

It was reported on May 13, that Kathryn Rowen, SVP at Vontier (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNT#NYSE">VNT</a>) executed a significant insider sell, according to an SEC filing.
What Happened: Rowen opted to sell 7,344 shares of Vontier, according to a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001786842/000178684225000034//Archives/edgar/data/1786842/000178684225000034/0001786842-25-000034-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday. The transaction's total worth stands at $266,873.
Vontier shares are trading up 0.89% at $36.95 at the time of this writing on Tuesday morning.
<h3>Get to Know Vontier Better</h3>
Vontier, spun off from Fortive in 2020, is an industrial technology company with a portfolio of transportation and mobility solutions. The company offers a wide array of products and services, including fueling equipment, sensors, point-of-sale and payment systems, telematics, and equipment used by vehicle mechanics and technicians. Vontier generated approximately $3 billion in sales in 2024.
<h3>Vontier: A Financial Overview</h3>
Negative Revenue Trend: Examining Vontier's financials over 3 months reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately -1.94% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Key Insights into Profitability Metrics:
<ul>
<li>
Gross Margin: The company maintains a high gross margin of 47.25%, indicating strong cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Vontier's EPS is below the industry average. The company faced challenges with a current EPS of 0.59. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: Vontier's debt-to-equity ratio surpasses industry norms, standing at 1.96. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current P/E ratio of 14.89 is below industry norms, indicating potential undervaluation and presenting an investment opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: The P/S ratio of 1.88 is lower than the industry average, implying a discounted valuation for Vontier's stock in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Indicated by a lower-than-industry-average EV/EBITDA ratio of 11.21, the company suggests a potential undervaluation, which might be advantageous for value-focused investors.
</li>
</ul>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Delving Into the Significance of Insider Transactions</h3>
While insider transactions provide valuable information, they should be part of a broader analysis in making investment decisions.
Considering the legal perspective, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, according to Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Nevertheless, insider sells may not necessarily indicate a bearish view and can be influenced by various factors.
<h3>Cracking Transaction Codes</h3>
For <a href="https://www.benzinga.com/money/investing-tools">investors</a>, a primary focus lies on transactions occurring in the open market, as indicated in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001786842">Check Out The Full List Of Vontier's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Decision: Kathryn Rowen Offloads $266K Worth Of Vontier Stock

Disclosed on May 13, Eric Nowak, President at Arrow Electronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARW#NYSE">ARW</a>), executed a substantial insider sell as per the latest SEC filing.
What Happened: According to a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000007536/000112760225014010//Archives/edgar/data/7536/000112760225014010/0001127602-25-014010-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday, Nowak sold 4,952 shares of Arrow Electronics. The total transaction value is $606,075.
Monitoring the market, Arrow Electronics's shares up by 0.41% at $122.25 during Tuesday's morning.
<h3>All You Need to Know About Arrow Electronics</h3>
Arrow Electronics Inc. is a provider of products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions. It has one of the world's broadest portfolios of product offerings available from electronic components and enterprise computing solutions suppliers, coupled with a range of services, solutions, and software, the company helps industrial and commercial customers introduce products, reduce their time to market, and enhance their overall competitiveness. The company has two business segments, the components business and the enterprise computing solutions.
<h3>A Deep Dive into Arrow Electronics's Financials</h3>
Decline in Revenue: Over the 3 months period, Arrow Electronics faced challenges, resulting in a decline of approximately -1.59% in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Profitability Metrics: Unlocking Value
<ul>
<li>
Gross Margin: The company shows a low gross margin of 11.36%, indicating concerns regarding cost management and overall profitability relative to its industry counterparts.
</li>
<li>
Earnings per Share (EPS): The company excels with an EPS that surpasses the industry average. With a current EPS of 1.53, Arrow Electronics showcases strong earnings per share.
</li>
</ul>
Debt Management: With a below-average debt-to-equity ratio of 0.48, Arrow Electronics adopts a prudent financial strategy, indicating a balanced approach to debt management.
Financial Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 16.75 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: The P/S ratio of 0.23 is lower than the industry average, implying a discounted valuation for Arrow Electronics's stock in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Arrow Electronics's EV/EBITDA ratio, lower than industry averages at 10.02, indicates attractively priced shares.
</li>
</ul>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Transactions Are Important</h3>
Emphasizing the importance of a comprehensive approach, considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.
Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
<h3>Unlocking the Meaning of Transaction Codes</h3>
Surveying the realm of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often give prominence to those unfolding in the open market, systematically detailed in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000007536">Check Out The Full List Of Arrow Electronics's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

President Of Arrow Electronics Sold $606K In Stock

A large exercise of company stock options by Pierre Beaudoin, Board Member at Coeur Mining (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDE#NYSE">CDE</a>) was disclosed in a new SEC filing on May 12, as part of an insider exercise.
What Happened: The latest Form 4 filing on Monday with the <a href="https://www.sec.gov/Archives/edgar/data/0000215466/000021546625000080//Archives/edgar/data/215466/000021546625000080/0000215466-25-000080-index.htm">U.S. Securities and Exchange Commission</a> uncovered Beaudoin, Board Member at Coeur Mining, exercising stock options for 80,551 shares of CDE. The total transaction was valued at $326,231.
Coeur Mining shares are trading, exhibiting up of 1.7% and priced at $7.79 during Tuesday's morning. This values Beaudoin's 80,551 shares at $326,231.
<h3>All You Need to Know About Coeur Mining</h3>
Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada, and Mexico.
<h3>Financial Milestones: Coeur Mining's Journey</h3>
Positive Revenue Trend: Examining Coeur Mining's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 69.0% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Materials sector.
Navigating Financial Profits:
<ul>
<li>
Gross Margin: The company faces challenges with a low gross margin of 31.3%, suggesting potential difficulties in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Coeur Mining's EPS reflects a decline, falling below the industry average with a current EPS of 0.06.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.19.
Valuation Overview:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current Price to Earnings ratio of 26.41 is higher than the industry average, indicating the stock is priced at a premium level according to the market sentiment.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 2.75, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio 14.09 is above the industry average, suggesting that the market values the company more highly for each unit of EBITDA. This could be attributed to factors such as strong growth prospects or superior operational efficiency.
</li>
</ul>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
From a legal standpoint, the term "insider" pertains to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as outlined in Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and significant hedge funds. These insiders are mandated to inform the public of their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
A company insider's new purchase is a indicator of their positive anticipation for a rise in the stock.
While insider sells may not necessarily reflect a bearish view and can be motivated by various factors.
<h3>Transaction Codes To Focus On</h3>
Taking a closer look at transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, meticulously cataloged in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A signifies a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000215466">Check Out The Full List Of Coeur Mining's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Board Member At Coeur Mining Exercises Options Worth $326K

On May 12, Jordan, Director at ESAB (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESAB#NYSE">ESAB</a>), executed a strategic insider move by acquiring stock options for 1,863 shares.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0001877322/000187732225000087//Archives/edgar/data/1877322/000187732225000087/0001877322-25-000087-index.htm">U.S. Securities and Exchange Commission</a> on Monday showed that Jordan, Director at ESAB, a company in the Industrials sector, acquired stock options for 1,863 shares of ESAB. The options allow Jordan to buy the company's stock at $125.93 per share.
As of Tuesday morning, ESAB shares are down by 0.0%, with a current price of $128.66. This implies that Jordan's 1,863 shares have a value of $5,085.
<h3>About ESAB</h3>
ESAB, spun off from Colfax in 2022, is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications. Alongside competitors Lincoln Electric and ITW's Miller brand, ESAB is one of the top three players in the welding space. ESAB generated roughly $2.7 billion in revenue in 2024.
<h3>Understanding the Numbers: ESAB's Finances</h3>
Revenue Challenges: ESAB's revenue growth over 3 months faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately -1.68%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Interpreting Earnings Metrics:
<ul>
<li>
Gross Margin: With a low gross margin of 37.63%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): ESAB's EPS lags behind the industry average, indicating concerns and potential challenges with a current EPS of 1.1.
</li>
</ul>
Debt Management: ESAB's debt-to-equity ratio surpasses industry norms, standing at 0.61. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
Financial Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The P/E ratio of 26.69 is lower than the industry average, implying a discounted valuation for ESAB's stock.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 2.88, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an impressive EV/EBITDA ratio of 16.84, ESAB demonstrates exemplary market valuation, surpassing industry averages.
</li>
</ul>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Navigating the Impact of Insider Transactions on Investments</h3>
It's important to note that insider transactions alone should not dictate investment decisions, but they can provide valuable insights.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Essential Transaction Codes Unveiled</h3>
Delving into transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> typically prioritize those unfolding in the open market, as precisely outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001877322">Check Out The Full List Of ESAB's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ESAB

Rhonda Jordan Expands Holdings With ESAB Stock Options Worth $5K

Star Bulk Carriers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBLK#NASDAQ">SBLK</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-05-14. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Star Bulk Carriers will report an earnings per share (EPS) of $-0.29.
The announcement from Star Bulk Carriers is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Performance in Previous Earnings</h3>
In the previous earnings release, the company missed EPS by $0.07, leading to a 8.72% drop in the share price the following trading session.
Here's a look at Star Bulk Carriers's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.41</td>
<td>0.73</td>
<td>0.83</td>
<td>0.81</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.34</td>
<td>0.71</td>
<td>0.78</td>
<td>0.87</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-9.0%</td>
<td>-5.0%</td>
<td>-0.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747148548_0.png" alt="eps graph" />
<h3>Performance of Star Bulk Carriers Shares</h3>
Shares of Star Bulk Carriers were trading at $16.2 as of May 12. Over the last 52-week period, shares are down 36.35%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<h3>Insights Shared by Analysts on Star Bulk Carriers</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Star Bulk Carriers.
Star Bulk Carriers has received a total of 1 ratings from analysts, with the consensus rating as Buy. With an average one-year price target of $21.0, the consensus suggests a potential 29.63% upside.
<h3>Comparing Ratings with Peers</h3>
The below comparison of the analyst ratings and average 1-year price targets of ZIM Integrated Shipping, Golden Ocean Group and Global Ship Lease, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Underperform trajectory for ZIM Integrated Shipping, with an average 1-year price target of $13.63, suggesting a potential 15.86% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Golden Ocean Group, with an average 1-year price target of $9.0, suggesting a potential 44.44% downside.</li>
<li>Analysts currently favor an Buy trajectory for Global Ship Lease, with an average 1-year price target of $29.0, suggesting a potential 79.01% upside.</li>
</ul>
<h3>Insights: Peer Analysis</h3>
Within the peer analysis summary, vital metrics for ZIM Integrated Shipping, Golden Ocean Group and Global Ship Lease are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Star Bulk Carriers</td>
<td>Buy</td>
<td>17.25%</td>
<td>$74.11M</td>
<td>1.70%</td>
</tr>
<tr>
<td>ZIM Integrated Shipping</td>
<td>Underperform</td>
<td>79.84%</td>
<td>$731M</td>
<td>14.10%</td>
</tr>
<tr>
<td>Golden Ocean Group</td>
<td>Neutral</td>
<td>-17.01%</td>
<td>$39.56M</td>
<td>2.04%</td>
</tr>
<tr>
<td>Global Ship Lease</td>
<td>Buy</td>
<td>2.28%</td>
<td>$99.10M</td>
<td>6.33%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Star Bulk Carriers ranks at the top for Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.
<h3>Unveiling the Story Behind Star Bulk Carriers</h3>
Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. It generates revenues through the voyages it carries out.
<h3>Unraveling the Financial Story of Star Bulk Carriers</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Positive Revenue Trend: Examining Star Bulk Carriers's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 17.25% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Industrials sector.
Net Margin: Star Bulk Carriers's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 13.74%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Star Bulk Carriers's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 1.7%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Star Bulk Carriers's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 1.03%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.59, Star Bulk Carriers adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/SBLK/earnings">To track all earnings releases for Star Bulk Carriers visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

SBLK

Preview: Star Bulk Carriers's Earnings

General

Caesars Entertainment Launches Its First Proprietary Online Casino Game, Caesars Palace Signature Multihand Blackjack Surrender, Now Live Exclusively On Caesars Palace Online Casino In New Jersey

In a new SEC filing on May 12, it was unveiled that ALLENDER, Director at ESAB (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESAB#NYSE">ESAB</a>), acquired stock options for 1,863 shares.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0001877322/000187732225000088//Archives/edgar/data/1877322/000187732225000088/0001877322-25-000088-index.htm">U.S. Securities and Exchange Commission</a> on Monday showed that ALLENDER, Director at ESAB, a company in the Industrials sector, acquired stock options for 1,863 shares of ESAB. The options allow ALLENDER to buy the company's stock at $125.93 per share.
ESAB shares are currently trading down by 0.0%, with a current price of $128.66 as of Tuesday morning. This brings the total value of ALLENDER's 1,863 shares to $5,085.
<h3>Discovering ESAB: A Closer Look</h3>
ESAB, spun off from Colfax in 2022, is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications. Alongside competitors Lincoln Electric and ITW's Miller brand, ESAB is one of the top three players in the welding space. ESAB generated roughly $2.7 billion in revenue in 2024.
<h3>ESAB's Economic Impact: An Analysis</h3>
Decline in Revenue: Over the 3 months period, ESAB faced challenges, resulting in a decline of approximately -1.68% in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Key Insights into Profitability Metrics:
<ul>
<li>
Gross Margin: The company faces challenges with a low gross margin of 37.63%, suggesting potential difficulties in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): ESAB's EPS lags behind the industry average, indicating concerns and potential challenges with a current EPS of 1.1.
</li>
</ul>
Debt Management: ESAB's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.61, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 26.69 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: The Price to Sales ratio is 2.88, which is lower than the industry average. This suggests a possible undervaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio 16.84 is above the industry average, suggesting that the market values the company more highly for each unit of EBITDA. This could be attributed to factors such as strong growth prospects or superior operational efficiency.
</li>
</ul>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Relevance of Insider Transactions</h3>
While insider transactions provide valuable information, they should be part of a broader analysis in making investment decisions.
Considering the legal perspective, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, according to Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Nevertheless, insider sells may not necessarily indicate a bearish view and can be influenced by various factors.
<h3>Navigating the World of Insider Transaction Codes</h3>
Surveying the realm of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often give prominence to those unfolding in the open market, systematically detailed in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001877322">Check Out The Full List Of ESAB's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Witness A Substantial Acquisition As PATRICK ALLENDER Acquires ESAB Stock Options Worth $5K

TMC Metals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>) is preparing to release its quarterly earnings on Wednesday, 2025-05-14. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect TMC Metals to report an earnings per share (EPS) of $-0.04.
The market awaits TMC Metals's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Overview of Past Earnings</h3>
During the last quarter, the company reported an EPS missed by $0.00, leading to a 1.18% increase in the share price on the subsequent day.
Here's a look at TMC Metals's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.05</td>
<td>-0.06</td>
<td>-0.05</td>
<td>-0.05</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.05</td>
<td>-0.06</td>
<td>-0.06</td>
<td>-0.08</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>4.0%</td>
<td>12.0%</td>
<td>-4.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747148538_0.png" alt="eps graph" />
<h3>TMC Metals Share Price Analysis</h3>
Shares of TMC Metals were trading at $3.14 as of May 12. Over the last 52-week period, shares are up 108.45%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/TMC/earnings">To track all earnings releases for TMC Metals visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights into TMC Metals's Upcoming Earnings

Data from Phase 1 clinical trial of ATH-1105 in healthy volunteers showed a favorable safety and tolerability profile; dose proportional pharmacokinetics and CNS penetration support continued clinical development
On-track to enable initiation of a clinical trial in ALS patients in late 2025
BOTHELL, Wash., May 13, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATHA#NASDAQ">ATHA</a>), a clinical stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that the Company will present data from a Phase 1 clinical trial of ATH-1105 in healthy volunteers at the 4th Annual ALS drug Development Summit taking place from May 12-14, 2025 in Boston, Massachusetts.
ATH-1105 is the Company's novel, orally available, brain-penetrant, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system for the potential treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS).

ATHA

Athira Pharma To Present Data From Phase 1 Clinical Trial Of ATH-1105 In Healthy Volunteers At 4Th Annual ALS Drug Development Summit

Disclosed in a recent SEC filing, ROBERT LUTZ, Board Member at ESAB (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESAB#NYSE">ESAB</a>), made a strategic move by acquiring company stock options on May 12,.
What Happened: Uncovered in a Form 4 filing on Monday with the <a href="https://www.sec.gov/Archives/edgar/data/0001877322/000187732225000089//Archives/edgar/data/1877322/000187732225000089/0001877322-25-000089-index.htm">U.S. Securities and Exchange Commission</a>, LUTZ, Board Member at ESAB, executed an insider options move. This move consisted of acquiring stock options for 1,863 shares of ESAB, granting LUTZ the right to purchase the company's stock at an exercise price of $125.93 per share.
The Tuesday morning market activity shows ESAB shares down by 0.0%, trading at $128.66. This implies a total value of $5,085 for LUTZ's 1,863 shares.
<h3>About ESAB</h3>
ESAB, spun off from Colfax in 2022, is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications. Alongside competitors Lincoln Electric and ITW's Miller brand, ESAB is one of the top three players in the welding space. ESAB generated roughly $2.7 billion in revenue in 2024.
<h3>Understanding the Numbers: ESAB's Finances</h3>
Revenue Challenges: ESAB's revenue growth over 3 months faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately -1.68%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.
Interpreting Earnings Metrics:
<ul>
<li>
Gross Margin: With a low gross margin of 37.63%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): ESAB's EPS is below the industry average. The company faced challenges with a current EPS of 1.1. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: ESAB's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.61, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
In-Depth Valuation Examination:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 26.69, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: The Price to Sales ratio is 2.88, which is lower than the industry average. This suggests a possible undervaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): ESAB's EV/EBITDA ratio, surpassing industry averages at 16.84, positions it with an above-average valuation in the market.
</li>
</ul>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Pay Attention to Insider Transactions</h3>
Insider transactions, although significant, should be considered within the larger context of market analysis and trends.
Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.
Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.
But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Important Transaction Codes</h3>
Navigating through the landscape of transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, precisely detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001877322">Check Out The Full List Of ESAB's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Smart Decision: ROBERT LUTZ Acquires ESAB Stock Options Worth $5K

Didier Teirlinck, Director at ESAB (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESAB#NYSE">ESAB</a>), reported acquisition of company stock options on May 12, according to a new SEC filing.
What Happened: In a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001877322/000187732225000093//Archives/edgar/data/1877322/000187732225000093/0001877322-25-000093-index.htm">U.S. Securities and Exchange Commission</a> on Monday, Teirlinck, Director at ESAB, acquired stock options for 1,863 shares of ESAB. These options provide Teirlinck with the right to purchase the company's stock at $125.93 per share.
Currently, ESAB shares are trading down 0.0%, priced at $128.66 during Tuesday's morning. This values Teirlinck's 1,863 shares at $5,085.
<h3>Discovering ESAB: A Closer Look</h3>
ESAB, spun off from Colfax in 2022, is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications. Alongside competitors Lincoln Electric and ITW's Miller brand, ESAB is one of the top three players in the welding space. ESAB generated roughly $2.7 billion in revenue in 2024.
<h3>ESAB's Financial Performance</h3>
Negative Revenue Trend: Examining ESAB's financials over 3 months reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately -1.68% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Insights into Profitability:
<ul>
<li>
Gross Margin: The company issues a cost efficiency warning with a low gross margin of 37.63%, indicating potential difficulties in maintaining profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): ESAB's EPS reflects a decline, falling below the industry average with a current EPS of 1.1.
</li>
</ul>
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 0.61, caution is advised due to increased financial risk.
Valuation Metrics: A Closer Look
<ul>
<li>
Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 26.69, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 2.88, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio of 16.84, the company's market valuation exceeds industry averages.
</li>
</ul>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
Insider transactions are not the sole determinant of investment choices, but they are a factor worth considering.
When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
A new purchase by a company insider is a indication that they anticipate the stock will rise.
On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Navigating the World of Insider Transaction Codes</h3>
Examining transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often concentrate on those unfolding in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001877322">Check Out The Full List Of ESAB's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

In A Strategic Move, Didier Teirlinck Acquires ESAB Stock Options Worth $5K: Enhancing Value

Jonathan Keyser, Chief Legal Officer at Verra Mobility (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRRM#NASDAQ">VRRM</a>), reported a large exercise of company stock options on May 12, according to a new SEC filing.
What Happened: Keyser, Chief Legal Officer at Verra Mobility, made a strategic move by exercising stock options for 12,382 shares of VRRM as detailed in a Form 4 filing on Monday with the <a href="https://www.sec.gov/Archives/edgar/data/0001682745/000106299325009134//Archives/edgar/data/1682745/000106299325009134/0001062993-25-009134-index.htm">U.S. Securities and Exchange Commission</a>. The transaction value amounted to $83,578.
During Tuesday's morning session, Verra Mobility shares up by 0.78%, currently priced at $24.5. Considering the current price, Keyser's 12,382 shares have a total value of $83,578.
<h3>Unveiling the Story Behind Verra Mobility</h3>
Verra Mobility Corp is a provider of smart mobility technology solutions, principally operating throughout the United States, Australia, Europe and Canada. The company develops and uses technology and data intelligence to help make transportation safer and easier. It operates in three segments namely Commercial Services, Government Solutions, and Parking Solutions. It generates maximum revenue from the Commercial Services segment. The commercial Services segment delivers tolling and violation management services to rental car companies, commercial fleet vehicle owners, and violation issuing authorities.
<h3>Unraveling the Financial Story of Verra Mobility</h3>
Revenue Growth: Verra Mobility's remarkable performance in 3 months is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 6.45%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company excelled with a growth rate higher than the average among peers.
Navigating Financial Profits:
<ul>
<li>
Gross Margin: The company maintains a high gross margin of 94.26%, indicating strong cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Verra Mobility's EPS is below the industry average. The company faced challenges with a current EPS of 0.2. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: Verra Mobility's debt-to-equity ratio stands notably higher than the industry average, reaching 3.56. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
Valuation Metrics: A Closer Look
<ul>
<li>
Price to Earnings (P/E) Ratio: With a higher-than-average P/E ratio of 115.76, Verra Mobility's stock is perceived as being overvalued in the market.
</li>
<li>
Price to Sales (P/S) Ratio: With a relatively high Price to Sales ratio of 4.52 as compared to the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an impressive EV/EBITDA ratio of 18.18, Verra Mobility demonstrates exemplary market valuation, surpassing industry averages.
</li>
</ul>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
In the complex landscape of investment decisions, investors should approach insider transactions as part of a comprehensive analysis, considering various elements.
Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.
Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.
But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Breaking Down the Significance of Transaction Codes</h3>
Delving into transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> typically prioritize those unfolding in the open market, as precisely outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001682745">Check Out The Full List Of Verra Mobility's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

VRRM

Strategic Sale: Jonathan Keyser Decides To Exercise Options Worth $83K At Verra Mobility

Belite Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLTE#NASDAQ">BLTE</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-05-14. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Belite Bio will report an earnings per share (EPS) of $-0.37.
Anticipation surrounds Belite Bio's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Earnings Track Record</h3>
During the last quarter, the company reported an EPS missed by $0.01, leading to a 0.84% increase in the share price on the subsequent day.
Here's a look at Belite Bio's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.31</td>
<td>-0.29</td>
<td>-0.25</td>
<td>-0.28</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.32</td>
<td>-0.28</td>
<td>-0.26</td>
<td>-0.33</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>1.0%</td>
<td>0.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747148528_0.png" alt="eps graph" />
<h3>Market Performance of Belite Bio's Stock</h3>
Shares of Belite Bio were trading at $61.99 as of May 12. Over the last 52-week period, shares are up 45.11%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/BLTE/earnings">To track all earnings releases for Belite Bio visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BLTE

Earnings Outlook For Belite Bio

Celcuity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELC#NASDAQ">CELC</a>) is set to give its latest quarterly earnings report on Wednesday, 2025-05-14. Here's what investors need to know before the announcement.
Analysts estimate that Celcuity will report an earnings per share (EPS) of $-0.86. 
Investors in Celcuity are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Performance in Previous Earnings</h3>
Last quarter the company missed EPS by $0.08, which was followed by a 8.11% drop in the share price the next day.
Here's a look at Celcuity's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.67</td>
<td>-0.70</td>
<td>-0.68</td>
<td>-0.71</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.75</td>
<td>-0.65</td>
<td>-0.58</td>
<td>-0.59</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-8.0%</td>
<td>-10.0%</td>
<td>-3.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747148517_0.png" alt="eps graph" />
<h3>Performance of Celcuity Shares</h3>
Shares of Celcuity were trading at $10.675 as of May 12. Over the last 52-week period, shares are down 38.65%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/CELC/earnings">To track all earnings releases for Celcuity visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CELC

A Peek at Celcuity's Future Earnings

Bitfarms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BITF#NASDAQ">BITF</a>) will release its quarterly earnings report on Wednesday, 2025-05-14. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Bitfarms to report an earnings per share (EPS) of $-0.04.
Anticipation surrounds Bitfarms's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Historical Earnings Performance</h3>
In the previous earnings release, the company beat EPS by $0.07, leading to a 11.58% drop in the share price the following trading session.
Here's a look at Bitfarms's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.04</td>
<td>-0.10</td>
<td>-0.10</td>
<td>-0.03</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.03</td>
<td>-0.08</td>
<td>-0.07</td>
<td>-0.02</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-12.0%</td>
<td>-7.000000000000001%</td>
<td>-1.0%</td>
<td>-5.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747148507_0.png" alt="eps graph" />
<h3>Performance of Bitfarms Shares</h3>
Shares of Bitfarms were trading at $1.09 as of May 12. Over the last 52-week period, shares are down 40.6%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/BITF/earnings">To track all earnings releases for Bitfarms visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BITF

Earnings Outlook For Bitfarms

Karooooo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KARO#NASDAQ">KARO</a>) is preparing to release its quarterly earnings on Wednesday, 2025-05-14. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Karooooo to report an earnings per share (EPS) of $0.40.
Investors in Karooooo are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Historical Earnings Performance</h3>
During the last quarter, the company reported an EPS beat by $0.05, leading to a 6.0% drop in the share price on the subsequent day.
Here's a look at Karooooo's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2025</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.38</td>
<td>0.39</td>
<td>0.36</td>
<td>0.34</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.43</td>
<td>0.38</td>
<td>0.38</td>
<td>0.36</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-6.0%</td>
<td>-16.0%</td>
<td>1.0%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747148500_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Karooooo were trading at $44.01 as of May 12. Over the last 52-week period, shares are up 66.35%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/KARO/earnings">To track all earnings releases for Karooooo visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

KARO

Insights into Karooooo's Upcoming Earnings

JMP Securities analyst Jordan Bender maintains Century Casinos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTY#NASDAQ">CNTY</a>) with a Market Outperform and lowers the price target from $4 to $3.

Price Target

Analyst Ratings

CNTY

JMP Securities Maintains Market Outperform on Century Casinos, Lowers Price Target to $3

ARS Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRY#NASDAQ">SPRY</a>) is set to give its latest quarterly earnings report on Wednesday, 2025-05-14. Here's what investors need to know before the announcement.
Analysts estimate that ARS Pharmaceuticals will report an earnings per share (EPS) of $-0.36. 
The announcement from ARS Pharmaceuticals is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Performance in Previous Earnings</h3>
During the last quarter, the company reported an EPS beat by $0.60, leading to a 13.63% drop in the share price on the subsequent day.
Here's a look at ARS Pharmaceuticals's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.12</td>
<td>-0.15</td>
<td>-0.12</td>
<td>-0.11</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.48</td>
<td>-0.20</td>
<td>-0.13</td>
<td>-0.11</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-14.000000000000002%</td>
<td>0.0%</td>
<td>-2.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747148491_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of ARS Pharmaceuticals were trading at $13.29 as of May 12. Over the last 52-week period, shares are up 47.07%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/SPRY/earnings">To track all earnings releases for ARS Pharmaceuticals visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SPRY

ARS Pharmaceuticals's Earnings: A Preview

The <a href="https://www.benzinga.com/cannabis">U.S. cannabis industry</a> added $1.3 billion in new legal sales in 2024, yet it lost more than 15,000 full-time jobs.
That's the contradiction at the center of the 2025 Cannabis Jobs Report, released Tuesday by cannabis staffing firm <a href="https://www.vangst.com/2025-jobs-report?utm_source=report&amp;utm_medium=PR&amp;utm_campaign=jobs+report&amp;utm_id=vangst-jobs-report">Vangst</a> in partnership with Whitney Economics. The annual analysis tracks job growth, revenue trends and workforce dynamics across every regulated state market.
According to the report, the U.S. cannabis sector now supports 425,002 full-time equivalent (FTE) jobs, a 3.4% decline from 2023. This drop came despite $30.1 billion in legal retail sales, a 4.5% increase year-over-year.
"The cannabis industry has shifted from a phase of hypergrowth to one of operational discipline," said Karson Humiston, CEO of Vangst. "Despite a slight decline in jobs, cannabis remains one of the nation's leading employment sectors."
<h3 class="wp-block-heading">A Flatline In Jobs, But A Jump In Sales</h3>
This marks the first notable employment contraction since the post-pandemic boom. Between 2017 and 2023, the industry added hundreds of thousands of new roles, but 2024 brought headwinds like tax pressure, oversupply and regulatory bottlenecks.
<h3 class="wp-block-heading">Cannabis Job Growth Since 2017</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="474" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13104546/Screen-Shot-2025-05-13-at-11.32.18-1024x474.png" alt="" class="wp-image-913666" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13104546/Screen-Shot-2025-05-13-at-11.32.18-1024x474.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13104546/Screen-Shot-2025-05-13-at-11.32.18-300x139.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13104546/Screen-Shot-2025-05-13-at-11.32.18-768x356.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13104546/Screen-Shot-2025-05-13-at-11.32.18-1536x711.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13104546/Screen-Shot-2025-05-13-at-11.32.18-2048x948.png 2048w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
While overall sales rose, employers shifted toward leaner staffing models to preserve margins. Many moved away from full-time hires and instead adopted temp-to-hire or seasonal strategies, especially in cultivation and processing.
<h3 class="wp-block-heading">State-By-State Shake-Up</h3>
Legal cannabis continues to be a major economic driver, especially in states that recently launched or expanded adult-use programs.
Top 5 states by cannabis job growth in 2024:
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th>State</th>
<th>Job Growth</th>
<th>% Change</th>
</tr>
</thead>
<tbody>
<tr>
<td>New York</td>
<td>+8,450</td>
<td>+209%</td>
</tr>
<tr>
<td>Mississippi</td>
<td>+532</td>
<td>+103%</td>
</tr>
<tr>
<td>Ohio</td>
<td>+2,496</td>
<td>+34%</td>
</tr>
<tr>
<td>New Jersey</td>
<td>+2,763</td>
<td>+23%</td>
</tr>
<tr>
<td>West Virginia</td>
<td>+606</td>
<td>+73%</td>
</tr>
</tbody>
</table>
</figure>
Conversely, several mature markets saw steep job losses:
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th>State</th>
<th>Job Losses</th>
<th>% Change</th>
</tr>
</thead>
<tbody>
<tr>
<td>Arizona</td>
<td>-10,749</td>
<td>-52%</td>
</tr>
<tr>
<td>Illinois</td>
<td>-7,466</td>
<td>-25%</td>
</tr>
<tr>
<td>Maine</td>
<td>-3,848</td>
<td>-51%</td>
</tr>
<tr>
<td>Colorado</td>
<td>-2,021</td>
<td>-9%</td>
</tr>
<tr>
<td>Michigan</td>
<td>-1,746</td>
<td>-4%</td>
</tr>
</tbody>
</table>
</figure>
<h3 class="wp-block-heading">States with Job Gains vs. Job Losses</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="742" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13104625/Screen-Shot-2025-05-13-at-11.32.31-1024x742.png" alt="" class="wp-image-913668" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13104625/Screen-Shot-2025-05-13-at-11.32.31-1024x742.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13104625/Screen-Shot-2025-05-13-at-11.32.31-300x217.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13104625/Screen-Shot-2025-05-13-at-11.32.31-768x557.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13104625/Screen-Shot-2025-05-13-at-11.32.31-1536x1114.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13104625/Screen-Shot-2025-05-13-at-11.32.31.png 1738w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
In Illinois, where the effective sales tax rate on cannabis is 36.25%, consumers continued to cross state lines for cheaper options. That tax pressure, combined with rising competition from hemp-derived THC and the illicit market, capped legal participation and limited hiring.
<h3 class="wp-block-heading">Strategic Staffing Replaces Expansion</h3>
Just 27.3% of cannabis businesses were profitable in 2024, according to Whitney Economics. Another 40% broke even, prompting many companies to restructure.
Also read: <a href="https://www.benzinga.com/markets/cannabis/25/05/45297889/germanys-cannabis-industry-hits-e500m-2500-pharmacies-now-dispense-211-grow-clubs-approved">Germany&#8217;s Cannabis Industry Hits 500 Million Euros: 2,500 Pharmacies Now Dispense, 211 Grow Clubs Approved</a>
Instead of growing headcount, companies prioritized:
<ul class="wp-block-list">
<li>Short-term or seasonal labor</li>
<li>Cross-functional teams</li>
<li>Operational efficiency over scale</li>
</ul>
"The industry is maturing, shifting from rapid expansion to smart, strategic growth," said Beau Whitney, chief economist at Whitney Economics.
<h3 class="wp-block-heading">States Lead While Federal Reform Stalls</h3>
A potential DEA reclassification of cannabis to Schedule III sparked optimism in early 2024. But a postponed hearing and election-year gridlock stalled progress.
With no major federal changes expected in 2025, state-level activity remains the primary driver. New York is projected to nearly double its retail sales this year, while Ohio's adult-use rollout continues. Maryland, despite a recent tax hike from 9% to 12%, is forecast for further growth.
Meanwhile, California, Illinois and Washington continue to face structural challenges, including high taxes and sluggish consumer participation.
<h3 class="wp-block-heading">Forecast: $34 Billion In Sales In 2025</h3>
Vangst and Whitney project legal cannabis sales will reach $34 billion by the end of 2025, a 13.1% increase over last year. Whether job numbers rebound will depend on market stability, consumer migration to legal channels and tax or compliance relief.
"What we're witnessing is not a slowdown, but a strategic reset," said Whitney. "The industry is adapting, adjusting and preparing for its next chapter."
Photo: Shutterstock. Charts courtesy of Vangst.

Cannabis

Cannabis Sales Are Up, But Jobs Are Down: Why Insiders Call It A Strategic Reset For Survival

Press Releases

Alzamend Neuro to Present at the Sequire Investor Summit

Alzamend Neuro Announces Completion of a Novel Head Coil by Tesla for Measuring Brain Structure Lithium Levels in Five Upcoming Phase II Clinical Trials at Massachusetts General Hospital

Alzamend Neuro Announces Initiation Date of First Phase II Clinical Trial of AL001 to take Place at Massachusetts General Hospital

Health Care

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Post-Traumatic Stress Disorder to take Place at Massachusetts General Hospital

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Major Depressive Disorder to take Place at Massachusetts General Hospital

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Alzheimer's Disease to take Place at Massachusetts General Hospital

Alzamend Neuro Partners with QMENTA, to Advance AI-Powered Imaging for its Phase II Clinical Trial of AL001 Study to Take Place at Massachusetts General Hospital

Alzamend Neuro Announces Reverse Stock Split

Alzamend Neuro Initiates First Phase II Clinical Trial of AL001 "Lithium in Brain" Study Taking Place at Massachusetts General Hospital

ALZN

180 Life Sciences

Azitra

Biodexa Pharmaceuticals plc - American Depositary Shares

Biodexa Pharmaceuticals

bioAffinity Technologies, Inc. - Common Stock

bioAffinity Technologies

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Hldgs

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics

Ensysce Biosciences

Galecto

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Lixte Biotechnology Holdings, Inc. - Common Stock

Lixte Biotechnology

Mustang Bio

Matinas Biopharma Holdings, Inc. Common Stock

Matinas BioPharma Hldgs

Oragenics

Palisade Bio

Plus Therapeutics

Sunshine Biopharma

SILO Pharma

Synaptogenix

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Tharimmune

VivoSim Labs

Windtree Therapeutics, Inc. - Common Stock

Windtree Therapeutics

Longevity Health Holdings, Inc. - Common Stock

Longevity Health Holdings

Xenetic Biosciences

Ascendiant Capital

Maxim Group

WIIM

ALZN stock has given up its prior gain. Alzamend Neuro shares were trading higher after the company announced it initiated the Phase 2 clinical trial of AL001.

Comments

Alzamend Neuro

Actualités

Dernières nouvelles pour Alzamend Neuro (NASDAQ:ALZN) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL